comparemela.com

Latest Breaking News On - Sharon barr - Page 2 : comparemela.com

AstraZeneca : Investor Day Biographies - MarketScreener

Investor Day 2024 Unlocking growth to 2030 and beyond Speaker biographies Pascal Soriot .

Japan
Cambridge
Cambridgeshire
United-kingdom
Delhi
India
Washington
United-states
Netherlands
Manchester
Georgetown-university
District-of-columbia

AZ, Amgen's asthma biologic Tezspire excels in trial for COPD

Amgen and AstraZeneca have reported data from a trial that showed the effectiveness of their asthma drug Tezspire in certain patients with COPD.

San-diego
California
United-states
Becs
Wien
Austria
American
Jay-bradner
Sharon-barr
Regeneron-dupixent
Verona-pharmaceuticals
Astrazeneca

Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease. The Phase IIa COURSE trial was a.

United-states
United-kingdom
Manchester
Cambridge
Cambridgeshire
Japan
American
America
Brendan-mcevoy
Sharon-barr
Dave-singh
Jillian-gonzales

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

WILMINGTON, Del. (BUSINESS WIRE) May 19, 2024

Japan
Cambridge
Cambridgeshire
United-kingdom
Manchester
United-states
American
America
Lymphopoietin-isoforms
Dave-singh
Brendan-mcevoy
Jillian-gonzales

AstraZeneca: research into respiratory diseases

AstraZeneca presents its latest research on major respiratory and immune diseases at ATS 2024.AstraZeneca will present new clinical and real-world data on its respiratory inhalation, biologics and.

Sharon-barr
Astrazeneca
Executive-vice-president
Biopharmaceuticals-business-unit
Markets

vimarsana © 2020. All Rights Reserved.